A Study of VRN101099 in Patients With HER2-Positive Solid Tumors

Clinical trial NCT06806982 · RECRUITING

Trial details

NCT number: NCT06806982
Sponsor: Voronoi, Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

HER2-positive Solid Tumors

Start date: 2025-02-17
Primary completion: 2026-05-01
Enrollment: 72

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.